Triclabendazole

Specifications

68786-66-3CAS Number

614-728-7EC Number

6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazoleIUPAC Name

C14H9Cl3N2OSChemical Formula

359.7 g/molMolecular Weight

Triclabendazole; 68786-66-3; Fasinex; Triclabendazol; Egaten; Triclabendazolum; DTXSID7043952; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole; NVP-EGA230; EGA230B; 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-; NSC-759250; 4784C8E03O; DTXCID5023952; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzodiazole; Egaten tm; 6-chloro-5-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole; RefChem:58513; Triclabendazole Micronized; P02BX04; 614-728-7; 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole; MFCD00864519; CPD000466357; MLS001424101; CHEMBL1086440; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole; NCGC00164610-01; SMR000466357; C14H9Cl3N2OS; 5-chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole; 6-[2,3-bis(chloranyl)phenoxy]-5-chloranyl-2-methylsulfanyl-1H-benzimidazole; Triclabendazol [INN-Spanish]; Triclabendazolum [INN-Latin]; CCRIS 8988; 6-Chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole; CGA 89317; UNII-4784C8E03O; Triclabendazole CRS; Fasinex (TN); CGA-89317; Egaten (TN); Triclabendazole (Standard); 1H-BENZIMIDAZOLE, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLTHIO)-; CGA-89317, Egaten; TRICLABENDAZOLE [MI]; Oprea1_236106; Triclabendazole (USAN/INN); TRICLABENDAZOLE [INN]; cid_50248; MLS000759473; MLS000876812; SCHEMBL165712; TRICLABENDAZOLE [USAN]; orb1310247; orb3024998; SCHEMBL3499260; TRICLABENDAZOLE [MART.]; SCHEMBL29394758; SCHEMBL29409229; TRICLABENDAZOLE [WHO-DD]; BDBM58491; CHEBI:94759; HY-B0621R; MSK5581; Triclabendazole [USAN:INN:BAN]; 5-Chloro-6-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole; HMS2051E16; HMS2232D14; HMS3370H02; HMS3393E16; HMS3652M16; HMS3715P16; HMS3744I09; HMS5082G16; KUC103451N; Pharmakon1600-01505786; CGA89317; HY-B0621; Tox21_112231; EBC-26788; EBC-84235; MSK5581-100A; MSK5581-100M; NSC759250; s4114; STK332284; TRICLABENDAZOLE [ORANGE BOOK]; AKOS005439340; AKOS015950804; MSK5581-1000M; AC-7627; AT10531; CCG-100881; CCG-268150; DB12245; FT28419; KS-5329; NC00131; NSC 759250; SB17173; 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLSULFANYL)-1H-1,3-BENZODIAZOLE; NCGC00164610-02; NCGC00164610-08; SBI-0207022.P001; Triclabendazole for system suitability CRS; CAS-68786-66-3; NS00000576; SW197511-2; Triclabendazole 100 |Ig/mL in Acetonitrile; Triclabendazole 100 microg/mL in Acetonitrile; D07364; Triclabendazole Solution in Methanol, 100ug/mL; AB00639964-10; AB00639964_12; AB00639964_13; Triclabendazole Solution in Methanol, 1000ug/mL; F079305; Q419739; SR-01000759363; SR-01000759363-4; Triclabendazole Solution in Acetonitrile, 100ug/mL; Triclabendazole, VETRANAL(TM), analytical standard; BRD-K81916719-001-05-5; BRD-K81916719-001-13-9; BRD-K81916719-001-14-7; Z3069281092; 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole; Triclabendazole, EuropePharmacopoeia (EP) Reference Standard; 5-Chloro-6-(2',3'-dichlorophenoxy)-2-(methylthio)benzimidazole; 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio) -1H-benzimidazole; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzimidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole; 5-[2,3-bis(chloranyl)phenoxy]-6-chloranyl-2-methylsulfanyl-1H-benzimidazole; 6-CHLORO-2-(METHYLSULFANYL)-1H-1,3-BENZIMIDAZOL-5-YL (2,3-DICHLOROPHENYL) ETHER; Triclabendazole for system suitability, EuropePharmacopoeia (EP) Reference Standard; JA9Synonyms